- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Mega Lifesciences PCL (MEGA)
The Mega Lifesciences share price today is 35.75, view BK MEGA stock exchange data. Track the latest Mega Lifesciences share price with real-time updates on MEGA stock performance including market cap, day range, 52-week range and dividend yield. Access MEGA charts, earnings dates and analyst estimates to support your investment decisions.
35.75
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
35.50
36.00
52 wk Range
27.75
40.00
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
35.5036.00
52 wk Range
27.7540.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.62%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.62%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MEGA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
42.71
Upside
+19.48%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
2_800x533_L_1412520354.jpg)
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell
Analyst Ratings
6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 42.71
(+19.48% Upside)
Mega Lifesciences PCL Earnings Call Summary for Q2/2026
- Mega We Care reported Q2 2026 EPS of $0.59 on revenue of $3.53B; shares fell 1.3% to $38.00 amid concerns over higher spending and softer cash flow.
- First-half revenue grew 11-12% with similar low-double-digit growth expected in H2 2026; management guided 8-12% growth for 2027 depending on product launches.
- Core Mega We Care gross margin reached 65% in H1; SG&A at 32.5% of sales expected to decline in H2 as marketing expenses moderate throughout the year.
- Company reaffirmed goal to double net profit by 2030 organically without M&A plans THB 2.6B capex through 2028 for plant upgrades and capacity expansion.
- Operating cash flow at 76% of net profit signals inventory buildup; working capital cycle at 150-155 days while dividend payout ratio maintained near 70%.
Last Updated: 01-09-2026, 11:14 am
Read Full TranscriptEarnings
Latest Release
13-08-2026
EPS / Forecast
0.59 / --
Revenue / Forecast
3.53B / --
Compare MEGA to Peers and Sector
Metrics to compare | MEGA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEGAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 14.2x | 26.4x | −0.4x | |
PEG Ratio | 0.81 | 0.96 | 0.00 | |
Price/Book | 3.0x | 2.9x | 2.6x | |
Price / LTM Sales | 2.1x | 3.3x | 3.0x | |
Upside (Analyst Target) | 23.1% | 32.8% | 54.5% | |
Fair Value Upside | Unlock | 13.2% | 7.0% | Unlock |
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. The company operates through three segments: Brands, Distribution, and Original Equipment Manufacture. It offers wellness and nutrition products, including medical and sports nutrition, general well-being, vitamins, probiotics, herbal medicines, and cough and cold medicines, as well as hair, kid’s, men’s, and women’s care products; and various health concerns products, such as allergy, bone and joint, gut, liver, diabetic, eye, heart, brain, sleep and anxiety, pain, and skin care, as well as blood circulation and memory. The company also provides prescription medicines for anti-allergic, anti-infective, cardiovascular system, central nervous system, dermatology, diabetes, gastrointestinal, gynecology, nephrology, oncology, ophthalmology, orthopedic, pain, respiratory, rheumatology, and urology areas under the MEGA We care brand name. In addition, it offers logistical and marketing services for trading and sale of goods manufactured by third parties comprising warehouse management, collections, and value-added services; natural and plant-based health foods; digital support solutions; and operation of wellness center. Further, the company is involved in social enterprise; and software design, development, and other services. It sells its products in in Southeast Asia, Sub-Saharan Africa, Australia, Europe, and South America. Mega Lifesciences Public Company Limited was incorporated in 1982 and is headquartered in Bangkok, Thailand.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Mega Lifesciences (MEGA) Share Price Today?
The Mega Lifesciences share price today is 35.75.
What is the current Mega Lifesciences (MEGA) share price and day range?
As of 19-09-2026, the Mega Lifesciences share price is 35.75, with a previous close of 35.75. The share price has ranged from 35.50 to 36.00 today, while the 52-week range spans from 27.75 to 40.00.
What Is the Mega Lifesciences Market Cap?
As of today, Mega Lifesciences market cap is 31.17B.
Does Mega Lifesciences Pay Dividends? What's The Current Dividend Yield?
The Mega Lifesciences dividend yield is 4.62%.
What Is the Mega Lifesciences (MEGA) Share Price Target?
The average 12-month share price target for Mega Lifesciences is 42.71, with a high estimate of 45 and a low estimate of 35. 6 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +19.48% Upside potential.
What Is Mega Lifesciences's Earnings Per Share (TTM)?
The Mega Lifesciences EPS (TTM) is 2.51.
When Is the Next Mega Lifesciences Earnings Date?
Mega Lifesciences will release its next earnings report on 16-11-2026.
From a Technical Analysis Perspective, Is MEGA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Mega Lifesciences Trade On?
Mega Lifesciences is listed and trades on the Thailand Stock Exchange.
What Is the Stock Symbol for Mega Lifesciences?
The stock symbol for Mega Lifesciences is "MEGA."
How Many Times Has Mega Lifesciences Stock Split?
Mega Lifesciences has split 0 times.
How Many Employees Does Mega Lifesciences Have?
Mega Lifesciences has 900 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.